U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT07476781) titled 'CSF and Blood Plasma Liquid Biopsy in Patients With Metastatic Solid Tumours and CNS Metastases or no CNS Metastases' on March 03.
Brief Summary: This is a prospective, single-centre feasibility study of CSF ctDNA conducted at the Sunnybrook Odette Cancer Centre (SOCC), Toronto, Canada, including multiple solid tumor, stratified into cohorts according to CNS disease involvement, including leptomeningeal disease (Cohort A), parenchymal brain metastases (Cohort B), and no evidence of CNS metastases (Cohort C).
Study Start Date: Dec. 12, 2025
Study Type: INTERVENTIONAL
Condition:
Solid Tumor Malignancies
Brain Metastasases
Leptome...